Numbers
- CSF leaks occur in approximately 2% of patients
Aetiology
- Fractures involving
- Frontal or ethmoidal sinuses
- Petrous temporal bone
Investigations
Beta-2 transferin (ß2Tr)
- General
- A Tau protein
- Molecule produced by neuraminidase activity within the brain.
- Current gold standard test for confirming CSF leaks in patients with posttraumatic rhinorrhoea.
- Numbers
- Sensitivity (99%)
- High Specificity (97%)
- Location
- Found in
- CSF
- Mainly
- Not in nasal secretions.
- Aqueous humour
- Perilymph
- Blood of patients with alcohol related chronic liver disease
- Technique
- A clotted blood sample and a sterile container containing the collected nasal or aural fluid are transported to a centralised laboratory for testing.
- Takes 24 to 48 h to perform the assay and because of the qualitative nature of the test,
- Expertise is needed to interpret the result.
Beta-trace protein (ßTP)
- General
- Second most common protein in the CSF after albumin,
- Produced mainly by the epithelial cells lining the leptomeninges and by the choroid plexus.
- Numbers
- Accuracy: 95.7-97.4%
- A negative predictive value of 97.1%
- A positive predictive value of 100%
- Function
- Important for the maturation and maintenance of the central nervous system.
- Location
- Found in other bodily fluids,
- Because its concentration in CSF is 32-35 times more than in plasma (14.6±4.6 mg/L in CSF and 0.46±0.13 mg/L in moderate variations of plasma ßTP (eg due to kidney injury) will not significantly affect results, and no control serum sample is need for the interpretation of the assay.
- Advantages
- Quantitative,
- Less expensive than ß2Tr,
- Takes under 15 mins to process.
- Cons
- Not suitable in patients with
- Bacterial meningitis
- Severely reduced glomerular filtration rates
- When ßTP levels are in the range of 1.31 and 1.69mg/L because nasal secretions are known to contain similar levels of ßTP making ßTP in these ranges not diagnostic.
Management
- Surgery
- Aimed at reducing the symptoms and risk of infection in cases with persistent CSF leaks or fistulae.
- Lumbar drainage
- To relieve CSF pressure
- Used for
- Spontaneous repair
- Surgical repairs
- Facilitating a route to administer intrathecal fluorescein for diagnostic purposes
- Risk of pneumocephalus and risk of intracranial infection
- Antibiotic prophylaxis
- No
- Pneumovax
- Types
- Pneumococcal conjugate vaccine (PCV13)
- Pneumococcal polysaccharide vaccine (PPSV23)
- If sinuses are involved
Outcome
- Majority of CSF leaks are self- limiting and resolve spontaneously within days
- Infection rates between
- 7% and 30% for TBI patients with CSF leaks, with each day of leakage increasing the risk of ascending intracranial infection